← Browse by Condition
Medical Condition

cms

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06436742 Phase 1
Recruiting

A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS)

Enrollment
16 pts
Location
United States, Canad...
Sponsor
argenx
View Trial →